PL404646A1 - Dietary composition based on whey protein concentrate and the use of exogenous amino acids to make this composition - Google Patents

Dietary composition based on whey protein concentrate and the use of exogenous amino acids to make this composition

Info

Publication number
PL404646A1
PL404646A1 PL404646A PL40464613A PL404646A1 PL 404646 A1 PL404646 A1 PL 404646A1 PL 404646 A PL404646 A PL 404646A PL 40464613 A PL40464613 A PL 40464613A PL 404646 A1 PL404646 A1 PL 404646A1
Authority
PL
Poland
Prior art keywords
composition
amino acids
dietary
make
whey protein
Prior art date
Application number
PL404646A
Other languages
Polish (pl)
Other versions
PL229405B1 (en
Inventor
Bogusław Achinger
Artur Kamzol
Original Assignee
Regis Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regis Spółka Z Ograniczoną Odpowiedzialnością filed Critical Regis Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL404646A priority Critical patent/PL229405B1/en
Publication of PL404646A1 publication Critical patent/PL404646A1/en
Publication of PL229405B1 publication Critical patent/PL229405B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Przedmiotem wynalazku jest kompozycja dietetyczna do postępowania dietetycznego po operacjach bariatrycznych oraz zastosowanie aminokwasów egzogennych do wytwarzania kompozycji dietetycznej. Preparat jest przeznaczony do postępowania dietetycznego u osób po operacjach z wycięciem fragmentu żołądka i/lub wytworzeniem pętli omijających anatomiczną ciągłość przewodu pokarmowego, w tym po operacjach bariatrycznych wykonywanych z powodu otyłości lub innych składowych zespołu metabolicznego (cukrzyca typu 2, nadciśnienie tętnicze, zaburzenia lipidowe) oraz u osób w okresie okołooperacyjnym przy operacjach w obrębie przewodu pokarmowego.The subject of the invention is a dietary composition for dietary management after bariatric operations and the use of exogenous amino acids for the preparation of a dietary composition. The preparation is intended for dietary management in persons after operations with gastrectomy and / or loops bypassing the anatomical continuity of the gastrointestinal tract, including after bariatric operations performed due to obesity or other components of the metabolic syndrome (type 2 diabetes, hypertension, lipid disorders) and in people in the perioperative period for gastrointestinal surgery.

PL404646A 2013-07-11 2013-07-11 Dietary composition based on whey protein concentrate and the use of exogenous amino acids to make this composition PL229405B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL404646A PL229405B1 (en) 2013-07-11 2013-07-11 Dietary composition based on whey protein concentrate and the use of exogenous amino acids to make this composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL404646A PL229405B1 (en) 2013-07-11 2013-07-11 Dietary composition based on whey protein concentrate and the use of exogenous amino acids to make this composition

Publications (2)

Publication Number Publication Date
PL404646A1 true PL404646A1 (en) 2015-01-19
PL229405B1 PL229405B1 (en) 2018-07-31

Family

ID=52305541

Family Applications (1)

Application Number Title Priority Date Filing Date
PL404646A PL229405B1 (en) 2013-07-11 2013-07-11 Dietary composition based on whey protein concentrate and the use of exogenous amino acids to make this composition

Country Status (1)

Country Link
PL (1) PL229405B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220288125A1 (en) * 2021-03-15 2022-09-15 Stokely-Van Camp, Inc. Nutritional Composition for Improving Sleep

Also Published As

Publication number Publication date
PL229405B1 (en) 2018-07-31

Similar Documents

Publication Publication Date Title
CY1119918T1 (en) Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
BR112015014237A2 (en) high caloric density and low viscosity oral nutritional composition and related methods
BR112015014420A2 (en) human milk oligosaccharides to improve stress symptoms
BR112015004734A2 (en) fusion proteins to treat a metabolic syndrome
DK2068637T3 (en) THE RICH OF THE MILK INGREDIENT WITH POLAR LIPIDS AND USES THEREOF
EA201291180A1 (en) COMPOSITIONS AND METHODS OF APPLICATION OF THERAPEUTIC ANTIBODIES AGAINST PROTEIN RELATED TO LOW DENSITY 6 LIPOPROTEIN RECEPTOR (LRP6)
FR2980966B1 (en) SURGICAL CLIP
IL222814A0 (en) Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (lrp6) multivalent antibodies
BR112013026539A2 (en) nutritional compositions having a-hica and a-ketoglutarate and methods of using them
EA200802184A1 (en) PHARMACEUTICAL COMPOSITIONS WITH DPP IV INHIBITORS
MX373251B (en) CALCITONIN MIMETICS FOR TREATING DISEASES AND DISORDERS.
BR112014009225A2 (en) use of whey protein micelles for young children at risk for obesity or diabetes
BR112015025392A2 (en) vaccine composition and method of use
EA201290172A1 (en) STABLE POLYPEPTIDES, VARIABLE DOMAINS ANTIBODIES AND ANTAGONISTS AGAINST TNFR1
CL2019001379A1 (en) A method for producing a dairy concentrate with aggregation of free divalent cation proteins.
PL417769A1 (en) Amino acid composition based on protein to be used before physical effort
MX374247B (en) RECENTLY IDENTIFIED PEPTIDES FOR USE IN THE INDUCTION OF ORAL TOLERANCE IN YOUNG MAMMALS.
BR112015000583A2 (en) hypo-allergenic crosslinked proteins for use in preventing a milk protein allergy and for use in inducing oral tolerance
MY179829A (en) Anti-regurgitation nutritional composition
WO2010102248A3 (en) Molecular tweezers for the treatment of amyloid-related diseases
Marunaka Importance of expression and function of angiotensin II receptor type 1 in pulmonary epithelial cells
Barker et al. The King's Brief Interstitial Lung Disease Questionnaire: response to pulmonary rehabilitation and minimal important difference
Damarla et al. Activation Of MAP Kinase Signaling In Response To Febrile Range Hyperthermia During Ventilator Associated Lung Injury
CN302256474S (en) Monitor (iM20)
CN302352356S (en) hemostatic bandage